» Articles » PMID: 15851714

Behavioural Treatments for Chronic Systemic Inflammation: Effects of Dietary Weight Loss and Exercise Training

Overview
Journal CMAJ
Date 2005 Apr 27
PMID 15851714
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent low-grade inflammation, as indicated by higher circulating levels of inflammatory mediators such as C-reactive protein, interleukin-6 and tumour necrosis factor-alpha, is a strong risk factor for several chronic diseases. There are data indicating that decreasing energy intake and increasing physical activity may be effective therapies for reducing overall inflammation. Evidence is strong that circulating levels of inflammatory markers are elevated with total and abdominal obesity, possibly owing to a higher secretion rate of cytokines by adipose tissue in obese people. Moreover, very-low-energy dietary weight loss reduces both circulating markers of inflammation and adipose-tissue cytokine production. Data from several large population-based cohorts show an inverse association between markers of systemic inflammation and physical activity or fitness status; small-scale intervention studies support that exercise training diminishes inflammation. Dietary weight loss plus exercise is likely more effective than weight reduction alone in reducing inflammation. To date, data from randomized, controlled trails designed to definitively test the effects of weight loss or exercise training, or both, on inflammation are limited. Future studies are required to define the amount of weight loss needed for clinically meaningful reductions of inflammation; in addition, fully powered and controlled studies are necessary to clarify the effect of exercise training on chronic, systemic inflammation.

Citing Articles

The evaluation of the inflammatory status and systemic antioxidant-oxidant balance of women with breast cancer during adjuvant chemotherapy.

Grupinska J, Budzyn M, Janowski J, Gryszczynska B, Kaja E, Brzezinski J Rep Pract Oncol Radiother. 2025; 29(4):488-500.

PMID: 39895965 PMC: 11785379. DOI: 10.5603/rpor.102130.


GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction.

Bonfioli G, Rodella L, Metra M, Vizzardi E Heart Fail Rev. 2024; 30(1):131-136.

PMID: 39425816 PMC: 11646221. DOI: 10.1007/s10741-024-10450-6.


Association of systemic immune-inflammation index with body mass index, waist circumference and prevalence of obesity in US adults.

Yang S, Zhang S, Deng J, Xie J, Zhang J, Jia E Sci Rep. 2024; 14(1):22086.

PMID: 39333666 PMC: 11436774. DOI: 10.1038/s41598-024-73659-3.


The Interplay between Structural Inequality, Allostatic Load, Inflammation, and Cancer in Black Americans: A Narrative Review.

Esdaille A, Kuete N, Anyaeche V, Kalemoglu E, Kucuk O Cancers (Basel). 2024; 16(17).

PMID: 39272881 PMC: 11394332. DOI: 10.3390/cancers16173023.


Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview.

Rathi N, Reche A Cureus. 2023; 15(10):e47169.

PMID: 38021744 PMC: 10652058. DOI: 10.7759/cureus.47169.


References
1.
Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M . Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab. 2000; 26(3):178-82. View

2.
Albert M, Danielson E, Rifai N, Ridker P . Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001; 286(1):64-70. DOI: 10.1001/jama.286.1.64. View

3.
Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G . Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab. 2002; 87(8):3864-6. DOI: 10.1210/jcem.87.8.8781. View

4.
Ridker P, Cannon C, Morrow D, Rifai N, Rose L, McCabe C . C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352(1):20-8. DOI: 10.1056/NEJMoa042378. View

5.
Wegge J, Roberts C, Ngo T, Barnard R . Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism. 2004; 53(3):377-81. DOI: 10.1016/j.metabol.2003.10.016. View